• Strategy
  • Payers
  • AI
  • Cybersecurity
  • Device Development
  • Studies/Published Research
  • Ethics
  • Regulatory
  • Digital Biomarkers
  • Data Science
  • Companion Diagnostics
  • Clinical Care
  • Digital Therapeutics
  • Academic Research
  • Virtual Reality
  • RWE
  • Digital Endpoints
  • Medical Devices (Class II and Class III)
  • Commercialization
  • Clinical Trials
  • Drug-Device Combinations
  • SaMD
  • Remote Patient Monitoring
  • Patient Engagement
  • Profiles/Q&A

Healint Launches Clinical Study to Verify AI Diagnosis of Migraine


The healthcare technology company is working with Saitama Medical University Hospital in Japan on the trial.

yodiyim, stock.adobe.com

Saitama Medical University Hospital and Healint launched one of the world's first clinical studies titled "Verification of Headache AI diagnosis by using Electronic Headache Diary in Telemedicine." About 20 renowned headache specialists participated from multiple locations, mainly in the Tokyo metropolitan area to conduct this research together. From the end of April, they plan to recruit more patients.

Although there are currently 30 million chronic headache patients in Japan, the diagnosis and treatment rate of migraine among non-headache specialists is less than 20%. Under these circumstances, there is an urgent need to develop tools to support the diagnosis of headache. The study is expected to validate how the AI can support a broad range of doctors in diagnosing patients, and each of their attacks, in order to select treatments as well as to potentially identify the symptom patterns associated with fatal conditions earlier.

Continue reading this story here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.